# Single Ascending Dose Study of PRX003 in Healthy Subjects

> **NCT02458677** · PHASE1 · COMPLETED · sponsor: **Prothena Biosciences Limited** · enrollment: 40 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** PRX003
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02458677
- **Lead sponsor:** Prothena Biosciences Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02458677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02458677, "Single Ascending Dose Study of PRX003 in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02458677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*